This Week in Longevity: April 28, 2026
FDA drops 12 peptides from its restricted list, Nature names GLP-1s the first longevity drug class, and the first human FMD autophagy trial is in. Catch up in 5 minutes.
Science-backed cellular optimization, longevity protocols, and the research behind feeling alive at every age.
FDA drops 12 peptides from its restricted list, Nature names GLP-1s the first longevity drug class, and the first human FMD autophagy trial is in. Catch up in 5 minutes.
Senescent “zombie cells” silently drive aging in women 35+. Learn what they are, why they accumulate, and how senolytics can help clear them.
If you’ve ever thought, “I’m doing everything right — sleeping, eating well, exercising — so why do I still feel
You know the research. You understand the principles. Here are seven specific actions you can take this month to meaningfully
Sleep is the most underestimated intervention in cellular medicine. Not because we don’t know it matters — everyone knows sleep
Perimenopause is often talked about as a hormonal event — declining estrogen, irregular cycles, hot flashes. That framing is accurate
BPC-157 is one of the most-researched therapeutic peptides, with evidence spanning gut healing, tissue repair, inflammation reduction, and nervous system
The gut microbiome conversation usually stays at the surface: eat more fiber, take a probiotic. What gets left out is
Collagen peptides are in your morning smoothie. Therapeutic peptides are in longevity medicine clinics. Both are called peptides. Both are
Inflammation gets a lot of press. But most of that conversation misses the most important piece: the difference between acute